Site Map

Optic glioma

Glioma - optic; Optic nerve glioma; Juvenile pilocytic astrocytoma; Brain cancer - optic glioma

Gliomas are tumors that grow in various parts of the brain. Optic gliomas can affect:

• One or both of the optic nerves that carry visual information to the brain from each eye
• The optic chiasm, the area where the optic nerves cross each other in front of the hypothalamus of the brain

An optic glioma may also grow along with a hypothalamic glioma.

Images

Causes

Optic gliomas are rare. The cause of optic gliomas is unknown. Most optic gliomas are slow-growing and noncancerous (benign) and occur in children, almost always before age 20. Most cases are diagnosed by 5 years of age.

There is a strong association between optic glioma and neurofibromatosis type 1 (NF1).

Symptoms

The symptoms are due to the tumor growing and pressing on the optic nerve and nearby structures. Symptoms may include:

• Involuntary eyeball movement
• Outward bulging of one or both eyes
• Squinting
• Vision loss in one or both eyes that starts with the loss of peripheral vision and eventually leads to blindness

The child may show symptoms of diencephalic syndrome, which includes:

• Daytime sleeping
• Decreased memory and brain function
• Headaches
• Delayed growth
• Loss of body fat
• Vomiting

Exams and Tests

A brain and nervous system (neurologic) examination reveals a loss of vision in one or both eyes. There may be changes in the optic nerve, including swelling or scarring of the nerve, or paleness and damage to the optic disc.

The tumor may extend into deeper parts of the brain. There may be signs of increased pressure in the brain (intracranial pressure). There may be signs of neurofibromatosis type 1 (NF1).

The following tests may be performed:

• Cerebral angiography
• Examination of tissue removed from the tumor during surgery or CT scan-guided biopsy to confirm the tumor type
• Head CT scan or MRI of the head
• Visual field tests

Treatment

Treatment varies with the size of the tumor and the general health of the person. The goal may be to cure the disorder, relieve symptoms, or improve vision and comfort.

Surgery to remove the tumor may cure some optic gliomas. Partial removal to reduce the size of the tumor can be done in many cases. This will keep the tumor from damaging normal brain tissue around it. Chemotherapy may be used in some children. Chemotherapy may be especially useful when the tumor extends into the hypothalamus or if vision has been worsened by the tumor's growth.

Radiation therapy may be recommended in some cases when the tumor is growing despite chemotherapy, and surgery is not possible. In some cases, radiation therapy may be delayed because the tumor is slow growing. Children with NF1 usually won't receive radiation due to the side effects.

Corticosteroids may be prescribed to reduce swelling and inflammation during radiation therapy, or if symptoms return.

Support Groups

Organizations that provide support and additional information include:

• Children's Oncology Group -- www.childrensoncologygroup.org
• Neurofibromatosis Network -- www.nfnetwork.org

Outlook (Prognosis)

The outlook is very different for each person. Early treatment improves the chance of a good outcome. Careful follow-up with a care team experienced with this type of tumor is important.

Once vision is lost from the growth of an optic tumor, it may not return.

Normally, the growth of the tumor is very slow, and the condition remains stable for long periods. However, the tumor can continue to grow, so it must be monitored closely.

When to Contact a Medical Professional

Contact your health care provider for any vision loss, painless bulging of the eye, or other symptoms of this condition.

Prevention

Genetic counseling may be advised for people with NF1. Regular eye exams may allow early diagnosis of these tumors before they cause symptoms.

Related Information

Hypothalamic tumor
Benign
Neurofibromatosis-1
Vision problems
Blindness and vision loss

References

Eberhart CG. Eye and ocular adnexa. In: Goldblum JR, Lamps LW, McKenney JK, Myers JL, eds. Rosai and Ackerman's Surgical Pathology. 11th ed. Philadelphia, PA: Elsevier; 2018:chap 45.

Goodden J, Mallucci C. Optic pathway hypothalamic gliomas. In: Winn HR, ed. Youmans and Winn Neurological Surgery. 7th ed. Philadelphia, PA: Elsevier; 2017:chap 207.

Olitsky SE, Marsh JD. Abnormalities of the optic nerve. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 649.

BACK TO TOP

Review Date: 10/28/2021  

Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Health Content Provider 06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.